Applied DNA Reports 2019 Year End and Fiscal Fourth Quarter Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. ANT
3. SPY
4. META
5. FFAI
6. FFR
7. FICO
8. CART
9. LLY
10. TSLA

Go back to Applied DNA Reports 2019 Year End and Fiscal Fourth Quarter Financial Results

Applied DNA Sciences (APDN) Misses Q4 EPS by 18c, Revenues Miss

December 12, 2019 4:15 PM EST

Applied DNA Sciences (NASDAQ: APDN) reported Q4 EPS of ($1.44), $0.18 worse than the analyst estimate of ($1.26). Revenue for the quarter came in at $1.7 thousand versus the consensus estimate of $2.11 million.

Fiscal Fourth Quarter 2019 Financial Results:

Revenues increased 40% for the fourth quarter of fiscal 2019 to $1.7 million, compared with $1.2 million reported in the same period of the prior fiscal year and decreased 19% from $2.1 million for the third quarter of fiscal 2019. The increase in revenues year over year was due primarily to an increase in product revenues from shipments of DNA concentrate to protect... More